Ionis Pharmaceuticals, Inc. (IONS) Total liabilities 2016–2025
Ionis Pharmaceuticals, Inc. (IONS) total liabilities at each fiscal year-end, per SEC filings.
$3.0BFY2025 · since FY2016: $812.9M → $3.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.0B | +25.6% |
| FY2024 | $2.4B | -7.2% |
| FY2023 | $2.6B | +32.8% |
| FY2022 | $2.0B | +6.6% |
| FY2021 | $1.8B | +11.8% |
| FY2020 | $1.6B | +6.3% |
| FY2019 | $1.5B | +4.6% |
| FY2018 | $1.5B | +54.6% |
| FY2017 | $957.5M | +17.8% |
| FY2016 | $812.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More IONS financial trends
IONS RevenueIONS Net incomeIONS Net marginIONS Gross profitIONS Gross marginIONS Operating incomeIONS Operating marginIONS Operating cash flowIONS Free cash flowIONS Capital expendituresIONS Return on equityIONS Stock buybacksIONS Dividends paidIONS Total assetsIONS Shareholders’ equityIONS overview →